Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05816694
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-04-18
First Post:
2023-03-27
Brief Title:
The Efficacy and Safety of Nanoparticle Albumin-bound NAB-Paclitaxel Plus Cisolation Versus CEP Cisplatin EpirubicinCyclophosphamide in Induction Therapy for Thymoma a Study for a Single-center Prospective Phase II Randomized Controlled Train
Sponsor:
Peng Liu
Organization:
Shanghai Zhongshan Hospital
Organization Data
Organization:
Shanghai Zhongshan Hospital
Class:
OTHER
Study ID:
B2021-584R2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peng Liu
Lead Sponsor Class:
OTHER
Responsible Party:
Peng Liu
Responsible Party Title:
Director
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Shanghai Zhongshan Hospital
Old Name:
None
Old Organization:
None